News & Updates

In the treatment of obesity in adolescents, the incidence of suicidal ideation or attempts appears to be lower among those receiving a glucagon-like peptide 1 receptor agonist (GLP1-RA) than among those undergoing lifestyle intervention alone, according to a retrospective study.

For patients with minor nondisabling acute ischaemic stroke without large vessel occlusion (LVO), dual antiplatelet therapy (DAPT) appears to prevent early neurological deterioration (END) with superior efficacy compared with intravenous alteplase while having a better safety profile, according to a post hoc analysis of the ARAMIS* trial.

EP-104IAR, a diffusion-based long-acting formulation of fluticasone propionate for intra-articular injection, appears to produce meaningful reductions in knee osteoarthritis (OA) pain that last up to 14 weeks, according to data from a phase II SPRINGBOARD study.

Treatment with belzutifan led to sustained improvements in progression-free survival (PFS) and objective response rate (ORR) among previously treated patients with advanced clear-cell renal cell carcinoma (RCC) compared with everolimus, according to findings from the final analysis of the phase III LITESPARK-005 trial presented at ESMO 2024.

Monitoring the body weight of the BMI of patients taking antidepressants does not seem to fully capture the adverse changes in body composition, a study has found. Such changes may result in a worsened cardiometabolic risk profile.